Review: Neuraminidase inhibitors relieve influenza symptoms and reduce laboratory-confirmed influenza in healthy adults

Smieja, Marek
February 2010
ACP Journal Club;2/16/2010, Vol. 152 Issue 2, p10
Academic Journal
The article focuses on studies whether neuraminidase inhibitors are effective for preventing or treating influenza in healthy adults. The studies compared neuraminidase inhibitors with placebo, antiviral controls, or no treatment in otherwise-healthy persons who were exposed to naturally occurring influenza. It was found that neuraminidase inhibitors relieve influenza symptoms and reduce risk for laboratory-confirmed influenza but not influenza-like illness or influenza complications.


Related Articles

  • Oseltamivir for Flu Prevention. Johnson, Julie M. // Journal of Family Practice;Feb2000, Vol. 49 Issue 2, p183 

    This article discusses a study on the use of selective oral neuraminidase inhibitor oseltamivir to prevent influenza. The study included 1,562 healthy subjects with a mean average age of 35 years and 63% were women. Researchers conducted two identical randomized placebo-controlled double blinded...

  • FDA Approval of New Indication for Oseltamivir. Preboth, Monica // American Family Physician;01/15/2001, Vol. 63 Issue 2, p378 

    Reports on the approval of a new indication for oseltamivir, a neuraminidase inhibitor previously approved for the treatment of uncomplicated influenza in adults, by the United States Food and Drug Administration. Description of the drug and its use; Side effects.

  • Oseltamivir Prophylactic Regimens Prevent H5N1 Influenza Morbidity and Mortality in a Ferret Model. Boltz, David A.; Rehg, Jerold E.; McClaren, Jennifer; Webster, Robert G.; Govorkova, Elena A. // Journal of Infectious Diseases;5/1/2008, Vol. 197 Issue 9, p1315 

    Background. Current oseltamivir prophylactic regimens may not be as effective against highly pathogenic H5N1 influenza viruses as they are against less pathogenic strains. An optimal regimen is urgently needed. Methods. Ferrets were given the neuraminidase inhibitor oseltamivir orally for 10...

  • The Value of Neuraminidase Inhibitors for the Prevention and Treatment of Seasonal Influenza: A Systematic Review of Systematic Reviews. Michiels, Barbara; Van Puyenbroeck, Karolien; Verhoeven, Veronique; Vermeire, Etienne; Coenen, Samuel // PLoS ONE;Apr2013, Vol. 8 Issue 4, p1 

    Controversy has arisen regarding the effectiveness of neuraminidase inhibitors (NIs), especially against influenza-related complications. A literature search was performed to critically assess the evidence collected by the available systematic reviews (SRs) regarding the benefits and...

  • Review: Antiviral agents reduce risk for influenza in healthy adults and alleviate symptoms faster than placebo.  // ACP Journal Club;Sep/Oct2006, Vol. 145 Issue 2, p45 

    The article focuses on a study, which cites that antiviral agents reduce risk of influenza in healthy adults. They also alleviate symptoms faster than placebo. The study also researched whether antiviral agents improve outcomes in affected persons. Randomization method and allocation concealment...

  • Recent Progress in Rational Drug Design of Neuraminidase Inhibitors. Yu Liu; Jie Zhang; Wenfang Xu // Current Medicinal Chemistry;2007, Vol. 14 Issue 27, p2872 

    Neuraminidase is a major glycoprotein of influenza virus which is essential for viral infection and offers a potential target for antiviral drug development. Rational drug design of NA inhibitors is now in the clinic and these molecules are effective and safe for the treatment of influenza....

  • Economics of Neuraminidase Inhibitor Stockpiling for Pandemic Influenza, Singapore. Lee, Vernon J.; Kai Hong Phua; Chen, Mark I.; Chow, Angela; Ma, Stefan; Kee Tai Goh; Yee Sin Leo // Emerging Infectious Diseases;Jan2006, Vol. 12 Issue 1, p95 

    We compared strategies for stockpiling neuraminidase inhibitors to treat and prevent influenza in Singapore. Cost-benefit and cost-effectiveness analyses, with Monte Carlo simulations, were used to determine economic outcomes. A pandemic in a population of 4.2 million would result in an...

  • Imaging of influenza virus sialidase activity in living cells. Kurebayashi, Yuuki; Takahashi, Tadanobu; Otsubo, Tadamune; Ikeda, Kiyoshi; Takahashi, Shunsaku; Takano, Maiko; Agarikuchi, Takashi; Sato, Tsubasa; Matsuda, Yukino; Minami, Akira; Kanazawa, Hiroaki; Uchida, Yuko; Saito, Takehiko; Kawaoka, Yoshihiro; Yamada, Toshihiro; Kawamori, Fumihiko; Thomson, Robin; von Itzstein, Mark; Suzuki, Takashi // Scientific Reports;5/2/2014, p1 

    Influenza virus is rich in variation and mutations. It would be very convenient for virus detection and isolation to histochemically detect viral infection regardless of variation and mutations. Here, we established a histochemical imaging assay for influenza virus sialidase activity in living...

  • Preventing and treating influenza. Stohr, Klaus // BMJ: British Medical Journal (International Edition);6/7/2003, Vol. 326 Issue 7401, p1223 

    Presents statistics from the World Health Organization (WHO) about the number of influenza cases worldwide. Drugs used in treating influenza including zanamivir and neuraminidase inhibitors; History of the use of neuraminidase inhibitors.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics